339 related articles for article (PubMed ID: 22532401)
41. Design and synthesis of hydroxypyridinone-L-phenylalanine conjugates as potential tyrosinase inhibitors.
Li DF; Hu PP; Liu MS; Kong XL; Zhang JC; Hider RC; Zhou T
J Agric Food Chem; 2013 Jul; 61(27):6597-603. PubMed ID: 23802151
[TBL] [Abstract][Full Text] [Related]
42. Tyrosinase inhibitory activities of cinnamic acid analogues.
Takahashi T; Miyazawa M
Pharmazie; 2010 Dec; 65(12):913-8. PubMed ID: 21284262
[TBL] [Abstract][Full Text] [Related]
43. Veratric acid derivatives containing benzylidene-hydrazine moieties as promising tyrosinase inhibitors and free radical scavengers.
Dehghani Z; Khoshneviszadeh M; Khoshneviszadeh M; Ranjbar S
Bioorg Med Chem; 2019 Jun; 27(12):2644-2651. PubMed ID: 31000406
[TBL] [Abstract][Full Text] [Related]
44. Synthesis of Some Novel 2-Substitutedbenzyl-(4)7-phenyl-1H-benzo[d]imidazoles in Mild Conditions as Potent Anti-Tyrosinase and Antioxidant Agents.
Doğan İS; Özel A; Birinci Z; Barut B; Sellitepe HE; Kahveci B
Arch Pharm (Weinheim); 2016 Nov; 349(11):881-888. PubMed ID: 27681014
[TBL] [Abstract][Full Text] [Related]
45. A class of potent tyrosinase inhibitors: alkylidenethiosemicarbazide compounds.
Liu J; Cao R; Yi W; Ma C; Wan Y; Zhou B; Ma L; Song H
Eur J Med Chem; 2009 Apr; 44(4):1773-8. PubMed ID: 18524420
[TBL] [Abstract][Full Text] [Related]
46. Oxazolones: new tyrosinase inhibitors; synthesis and their structure-activity relationships.
Khan KM; Mughal UR; Khan MT; Zia-Ullah ; Perveen S; Choudhary MI
Bioorg Med Chem; 2006 Sep; 14(17):6027-33. PubMed ID: 16750372
[TBL] [Abstract][Full Text] [Related]
47. 1,2,3-Triazole-linked 5-benzylidene (thio)barbiturates as novel tyrosinase inhibitors and free-radical scavengers.
Ranjbar S; Shahvaran PS; Edraki N; Khoshneviszadeh M; Darroudi M; Sarrafi Y; Hamzehloueian M; Khoshneviszadeh M
Arch Pharm (Weinheim); 2020 Oct; 353(10):e2000058. PubMed ID: 32638438
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis, and antimelanogenic effects of (2-substituted phenyl-1,3-dithiolan-4-yl)methanol derivatives.
Kim DH; Kim SJ; Ullah S; Yun HY; Chun P; Moon HR
Drug Des Devel Ther; 2017; 11():827-836. PubMed ID: 28352157
[TBL] [Abstract][Full Text] [Related]
49. N-[(Dihydroxyphenyl)acyl]serotonins as potent inhibitors of tyrosinase from mouse and human melanoma cells.
Yamazaki Y; Kawano Y; Yamanaka A; Maruyama S
Bioorg Med Chem Lett; 2009 Aug; 19(15):4178-82. PubMed ID: 19524439
[TBL] [Abstract][Full Text] [Related]
50. Benzo[b]thiophene-thiazoles as potent anti-Toxoplasma gondii agents: Design, synthesis, tyrosinase/tyrosine hydroxylase inhibitors, molecular docking study, and antioxidant activity.
Rosada B; Bekier A; Cytarska J; Płaziński W; Zavyalova O; Sikora A; Dzitko K; Łączkowski KZ
Eur J Med Chem; 2019 Dec; 184():111765. PubMed ID: 31629163
[TBL] [Abstract][Full Text] [Related]
51. Synthesis of aryl pyrazole via Suzuki coupling reaction, in vitro mushroom tyrosinase enzyme inhibition assay and in silico comparative molecular docking analysis with Kojic acid.
Channar PA; Saeed A; Larik FA; Batool B; Kalsoom S; Hasan MM; Erben MF; El-Seedi HR; Ali M; Ashraf Z
Bioorg Chem; 2018 Sep; 79():293-300. PubMed ID: 29793142
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of tyrosinase by 4H-chromene analogs: Synthesis, kinetic studies, and computational analysis.
Brasil EM; Canavieira LM; Cardoso ÉTC; Silva EO; Lameira J; Nascimento JLM; Eifler-Lima VL; Macchi BM; Sriram D; Bernhardt PV; Silva JRA; Williams CM; Alves CN
Chem Biol Drug Des; 2017 Nov; 90(5):804-810. PubMed ID: 28390091
[TBL] [Abstract][Full Text] [Related]
53. Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic.
Lachowicz JI; Nurchi VM; Crisponi G; Pelaez Mde G; Rescigno A; Stefanowicz P; Cal M; Szewczuk Z
J Inorg Biochem; 2015 Oct; 151():36-43. PubMed ID: 26239546
[TBL] [Abstract][Full Text] [Related]
54. Tyrosinase inhibitory effect of benzoic acid derivatives and their structure-activity relationships.
Khan SB; Hassan Khan MT; Jang ES; Akhtar K; Seo J; Han H
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):812-7. PubMed ID: 20476840
[TBL] [Abstract][Full Text] [Related]
55. Chalcones as potent tyrosinase inhibitors: the importance of a 2,4-substituted resorcinol moiety.
Khatib S; Nerya O; Musa R; Shmuel M; Tamir S; Vaya J
Bioorg Med Chem; 2005 Jan; 13(2):433-41. PubMed ID: 15598564
[TBL] [Abstract][Full Text] [Related]
56. Design and synthesis of biphenyl derivatives as mushroom tyrosinase inhibitors.
Bao K; Dai Y; Zhu ZB; Tu FJ; Zhang WG; Yao XS
Bioorg Med Chem; 2010 Sep; 18(18):6708-14. PubMed ID: 20729091
[TBL] [Abstract][Full Text] [Related]
57. Kinetics and inhibition study of tyrosinase by pressure mediated microanalysis.
Liu DM; Yang JL; Ha W; Chen J; Shi YP
Anal Biochem; 2017 May; 525():54-59. PubMed ID: 28257907
[TBL] [Abstract][Full Text] [Related]
58. Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies.
Abbas Q; Ashraf Z; Hassan M; Nadeem H; Latif M; Afzal S; Seo SY
Drug Des Devel Ther; 2017; 11():2029-2046. PubMed ID: 28740364
[TBL] [Abstract][Full Text] [Related]
59. Kojic acid-natural product conjugates as mushroom tyrosinase inhibitors.
Ashooriha M; Khoshneviszadeh M; Khoshneviszadeh M; Rafiei A; Kardan M; Yazdian-Robati R; Emami S
Eur J Med Chem; 2020 Sep; 201():112480. PubMed ID: 32652434
[TBL] [Abstract][Full Text] [Related]
60. 1,3,4-Oxadiazole-2(3H)-thione and its analogues: a new class of non-competitive nucleotide pyrophosphatases/phosphodiesterases 1 inhibitors.
Khan KM; Fatima N; Rasheed M; Jalil S; Ambreen N; Perveen S; Choudhary MI
Bioorg Med Chem; 2009 Nov; 17(22):7816-22. PubMed ID: 19822431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
